Engineered Nanoparticles for Drug Delivery in Cancer Therapy
The DOI matches its Crossref record; 579 of the 579 references it cites were found in a registry or an index.
Abstract
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half‐life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real‐time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next‐generation platform for cancer therapy and many other biomedical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Vasculature plays an essential role in the growth and metastasis of malignant tumors [103].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
Citations
Cites
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Chemistry and Properties of Nanocrystals of Different Shapes
Burda, C., Chen, X., Narayanan, R., & El-Sayed, M. A. (2005) · Chemical Reviews · doi:10.1021/cr030063a · Cited by 7,230
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Research works printed but not linked: 29
- Aruna U., 2013, Inter. J. Inn. Pharm. Res., 4, 318
- Langer R., 1998, Nature, 392, 5
- Petre C. E., 2007, Int. J. Nanomed., 2, 277
- Lao J., 2013, J. Drug Delivery, 456409
- Saif M. W., 2007, JOP, 8, 166
- Matsumura Y., 1986, Cancer Res., 46, 6387
- Xu G., 2001, Clin. Cancer Res., 7, 3314
- 10.1016/j.addr.2012.09.008 · doi:10.1016/j.addr.2012.09.008 · Paper page
- Pundir S., 2013, Int. J. Drug Res. Technol., 3, 12
- 10.1021/jp077468 · doi:10.1021/jp077468
- Mohanraj V. J., 2006, J. Pharm. Res., 5, 561
- Ma Y. D., 2011, Int. J. Nanomed., 6, 2679
- 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F · doi:10.1002/(sici)1097-4636(199908)46:2<236::aid-jbm13>3.0.co;2-f
- Krishna R., 2000, Eur. J. Cancer Sci., 11, 265
- Kettiger H., 2013, Int. J. Nanomed., 8, 3255
- Yuan F., 1995, Cancer Res., 55, 3752
- Jain R. K., 1987, Cancer Res., 47, 3039
- 10.1021/nn900002m · DOI · Paper page
- Chidambaram M., 2012, Int. J. Pharm. Sci., 2, 117
- 10.1039/C1CS15237H · DOI · Paper page
- 10.1038/nnano.2007.223 · DOI · Paper page
- Mohanraj V. J., 2006, Trop. J. Pharm. Res., 5, 561
- Hong R. L., 1999, Clin. Cancer Res., 5, 3645
- Shamsipour F., 2009, Avicenna J. Med. Biotechnol., 1, 27
- Park J. W., 2002, Clin. Cancer Res., 8, 1172
- Uppada S. B., 2014, Int. J. Nanomed., 9, 43
- Bangham A. D., 1965, J. Mol. Biol., 13, 227
- Mueller C., 1994, Methods Cell Sci., 16, 183
- 10.1016/j.cbpa.2005.10.005 · DOI
Cited by
Items 801–900 of 1,005
Xu, H., & Casabianca, L. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-69185-7 · Cited by 42
“This may be due to the aromatic nature of histidine, and pi–pi interactions (1) S(t) = Smax (”
BackgroundAn Update of Nanoparticle-Based Approaches for Glioblastoma Multiforme Immunotherapy
Taiarol, L., Formicola, B., Magro, R. D., Sesana, S., & Re, F. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0132 · Cited by 44
Rational nanocarrier design towards clinical translation of cancer nanotherapy
Guo, D., Ji, X., & Luo, J. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe35a · Cited by 40
“Derived and Reprinted with permission from [28].”
Yang, L., Sun, H. R., Liu, Y., Hou, W., Yang, Y. P., Cai, R., Cui, C., Zhang, P., Pan, X., Li, X., et al. (2018) · Angewandte Chemie · doi:10.1002/ange.201809753 · Cited by 40
Molecular targeted therapy: A new avenue in glioblastoma treatment (Review)
Atat, O. E., Naser, R., Abdelkhalek, M., Abi‐Habib, R. J., & El‐Sibai, M. (2022) · Oncology Letters · doi:10.3892/ol.2022.13632 · Cited by 52
“NPs are usually loaded with drugs and are known to have a small size within a range between 1‑100 nm (258).”
Shuai, Y., Yang, S., Li, C., Zhu, L., Mao, C., & Yang, M. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00208d · Cited by 38
Self-citationKiani Shahvandi, M., Souri, M., Tavasoli, S., Moradi Kashkooli, F., Kar, S., & Soltani, M. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107574 · Cited by 37
Therapeutic Nanoparticles: Recent Developments and Their Targeted Delivery Applications
Kumar, M., Kumar, U., & Singh, A. K. (2022) · Nano Biomedicine and Engineering · doi:10.5101/nbe.v14i1.p38-52 · Cited by 45
Huang, C., Zhou, Y., Tong, Q., Duan, Q.-J., Zhang, Q. H., Du, J., & Yao, X. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121827 · Cited by 40
Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery
Khan, M. S., Appak‐Baskoy, S., Yang, C. J., Hong, J., Chae, J., Ha, H.-J., Lee, S., Tanaka, M., Choi, Y., & Choi, J. H. (2023) · Nanoscale Advances · doi:10.1039/d2na00795a · Cited by 41
Advanced hitchhiking nanomaterials for biomedical applications
Wang, Y., Sun, S., Liu, Y., & Zhang, Z. (2023) · Theranostics · doi:10.7150/thno.88002 · Cited by 40
“presented a sulfonated azocalix[5]arene (SAC5A) for tumor-targeted delivery of paclitaxel (PTX) [9].”
Rajora, A. K., Ahire, E. D., Rajora, M. A. K., Singh, S., Bhattacharya, J., & Zhang, H. (2024) · Smart Medicine · doi:10.1002/smmd.20230035 · Cited by 42
Sthuthi Jose, M., & Sumathi, S. (2025) · Journal of Science Advanced Materials and Devices · doi:10.1016/j.jsamd.2025.100933 · Cited by 68
You, Y., Hu, H., He, L., & Chen, T. (2015) · Chemistry - An Asian Journal · doi:10.1002/asia.201500769 · Cited by 38
Calcite Single Crystals as Hosts for Atomic‐Scale Entrapment and Slow Release of Drugs
Magnabosco, G., Giosia, M. D., Polishchuk, I., Weber, E., Fermani, S., Bottoni, A., Zerbetto, F., Pelicci, P. G., Pokroy, B., Rapino, S., et al. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500170 · Cited by 37
Drug-loaded pseudo-block copolymer micelles with a multi-armed star polymer as the micellar exterior
Xie, C., Zhang, P., Zhang, Z., Yang, C., Zhang, J., Wu, W., & Jiang, X. (2015) · Nanoscale · doi:10.1039/c5nr02861b · Cited by 38
Bahhaj, F. E., Denis, I., Pichavant, L., Delatouche, R., Collette, F. M., Linot, C., Pouliquen, D., Grégoire, M., Héroguez, V., Blanquart, C., et al. (2016) · Theranostics · doi:10.7150/thno.13725 · Cited by 41
“(16),(17),(18) With epigenetic targeting drugs, side effects or systemic toxicity can be reduced with highly active compounds used alone or in combination, at low dosage, in association with the tumor targeting mediated by drug delivery systems (DDS).(19) In contrast to the reported DDS applications in epigenetics,(20…”
BackgroundXu, Z., Shi, X., Hou, M., Xue, P., Gao, Y.-E., Liu, S., & Kang, Y. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.11.021 · Cited by 37
Red blood cell-derived nanovesicles for safe and efficient macrophage-targeted drug delivery in vivo
Wan, X., Zhang, S., Wang, F., Fan, W., Wu, C., Mao, K., Wang, H., Hu, Z., Yang, Y., & Sun, T. (2018) · Biomaterials Science · doi:10.1039/c8bm01258j · Cited by 39
Self-citationBioceramics: from bone substitutes to nanoparticles for drug delivery
Vallet‐Regí, M. (2019) · Pure and Applied Chemistry · doi:10.1515/pac-2018-0505 · Cited by 39
Ke, X., Tang, H., & Mao, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.053 · Cited by 37
OFF–ON nanodiamond drug platform for targeted cancer imaging and therapy
Wei, S., Li, L., Du, X., & Li, Y. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00447e · Cited by 37
Yan, Y. J., Dong, Y., Yue, S., Qiu, X., Sun, H., & Zhong, Z. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b17223 · Cited by 37
Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment
Cordani, M., Strippoli, R., & Somoza, Á. (2019) · Cancers · doi:10.3390/cancers12010025 · Cited by 40
Light-Triggered Polymersome-Based Anticancer Therapeutics Delivery
Becerra, E. H., Quinchía, J., Castro, C. I., & Orozco, J. (2022) · Nanomaterials · doi:10.3390/nano12050836 · Cited by 41
“Surface modifications, mainly PEGylation, are widely used to reduce opsonization and, consequently, increase the circulation half-life of NPs [32,45].”
BackgroundInfluentialAdnane, F., Elzayat, E. M., & Fahmy, H. M. (2022) · Tissue and Cell · doi:10.1016/j.tice.2022.101856 · Cited by 46
Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases
Meng, X., Zhu, G., Yang, Y., & Sun, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116702 · Cited by 41
Self-citationMetal nanoparticles in neuroinflammation: impact on microglial dynamics and CNS function
Alaei, M., Koushki, K., Taebi, K., Taba, M. Y., Hedayati, S. K., & Shahbaz, S. K. (2025) · RSC Advances · doi:10.1039/d4ra07798a · Cited by 46
Maleimide-based acyclic enediyne for efficient DNA-cleavage and tumor cell suppression
Song, D., Sun, S., Tian, Y., Huang, S., Ding, Y., Yuan, Y., & Hu, A. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb02018a · Cited by 36
Han, K., Zhu, J., Wang, S., Li, Z.-H., Cheng, S., & Zhang, X. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01659b · Cited by 36
Yang, X., He, D., He, X., Wang, K., Tang, J., Zou, Z., He, X., Xiong, J. J., Li, L., & Shangguan, J. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b05065 · Cited by 36
Ye, Z., Wei, L., Zeng, X., Weng, R., Shi, X., Wang, N., Chen, L., & Xiao, L. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b03762 · Cited by 37
Fang, T., Ye, Z., Wu, J., & Wang, H. (2018) · Chemical Communications · doi:10.1039/c8cc03763a · Cited by 36
Cuggino, J. C., Gatti, G., Picchio, M. L., Maccioni, M., Gugliotta, L. M., & Igarzabal, C. I. Á. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.04.031 · Cited by 36
Haryadi, B. M., Hafner, D., Amin, I., Schubel, R., Jordan, R., Winter, G., & Engert, J. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900352 · Cited by 37
Taleblou, N., Sirousazar, M., Hassan, Z. M., & Khaligh, S. G. (2019) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2019.1675225 · Cited by 37
“If the rapid growth and spread of cancerous cells are not controlled, they can cause death [2].”
BackgroundRecent advances of bioresponsive polymeric nanomedicine for cancer therapy
Hong, T., Shen, X., Syeda, M. Z., Zhang, Y., Sheng, H. N., Zhou, Y., Xu, J., Zhu, C., Li, H., Gu, Z., et al. (2022) · Nano Research · doi:10.1007/s12274-022-5002-2 · Cited by 37
“The therapeutic efficacy and safety profiles of current tumor treatments, such as immunotherapy and chemotherapy, are still unfavorable, which is largely ascribed to the poor biodistribution of therapeutic drugs [6, 7].”
BackgroundSelf-citationHöcherl, A., Jäger, E., Jäger, A., Hrubý, M., Konefał, R., Janoušková, O., Spěváček, J., Jiang, Y., Schmidt, P. W., Lodge, T. P., et al. (2017) · Polymer Chemistry · doi:10.1039/c7py00270j · Cited by 37
Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapy
Zandieh, M. A., Farahani, M. H., Daryab, M., Motahari, A., Gholami, S., Salmani, F., Karimi, F., Samaei, S. S., Rezaee, A., Rahmanian, P., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115283 · Cited by 39
Felber, M., Bauwens, M., Mateos, J. M., Imstepf, S., Mottaghy, F. M., & Alberto, R. A. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201405704 · Cited by 35
Next Generation Multiresponsive Nanocarriers for Targeted Drug Delivery to Cancer Cells
Altenbuchner, P. T., Werz, P. D. L., Schöppner, P., Adams, F., Kronast, A., Schwarzenböck, C., Pöthig, A., Jandl, C., Haslbeck, M., & Rieger, B. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201601822 · Cited by 38
Interaction Pathways between Plasma Membrane and Block Copolymer Micelles
Guan, Z., Wang, L., & Lin, J. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.6b01674 · Cited by 36
Gold nanocages with dual modality for image-guided therapeutics
Bao, S., Huang, S., Liu, Y., Hu, Y., Wang, W., Ji, M., Li, H., Zhang, N. X., Song, C., & Duan, S. (2017) · Nanoscale · doi:10.1039/c7nr01350g · Cited by 36
Li, T., Zhou, J., Zhang, C., Zhi, X., Niu, J., Fu, H., Song, J., & Cui, D. (2018) · NPG Asia Materials · doi:10.1038/s41427-018-0094-6 · Cited by 37
Owoseni-Fagbenro, K. A., Saifullah, S., Imran, M. A., Perveen, S., Rao, K., Fasina, T. M., Olasupo, I. A., Adams, L. A., Ali, I., & Shah, M. R. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.02.002 · Cited by 35
“NPs offer distinct advantages such as increased bioavailability and blood half-life of poor aqueous soluble drugs due to thei r protection during transit to target sites, ondemand release, loading of multiple drugs and/or di agnostic agents, real-time therapeutic outcomes and improved targeted delivery with their mini…”
BackgroundHe, H., Zhuang, W., Ma, B., Su, X., Yu, T., Hu, J. X., Chen, L., Peng, R., Li, G., & Wang, Y. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00212 · Cited by 35
Adaptive Polymeric Assemblies for Applications in Biomimicry and Nanomedicine
Altay, Y., Cao, S., Che, H., Abdelmohsen, L. K. E. A., & van Hest, J. C. M. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b01341 · Cited by 36
Celastrol Self-Stabilized Nanoparticles for Effective Treatment of Melanoma
Li, J., Jia, Y., Zhang, P., Yang, H., Cong, X., An, L., & Xiao, C. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s232603 · Cited by 36
Braga, C. B., Kido, L. A., Lima, E. N., Lamas, C. A., Cagnon, V. H. A., Ornelas, C., & Pilli, R. A. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00057 · Cited by 35
Garrido‐Cano, I., Candela‐Noguera, V., Herrera, G., Cejalvo, J. M., Lluch, A. M., Marcos, M. D., Sancenón, F., Eroles, P., & Martínez‐Máñez, R. (2020) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2020.110593 · Cited by 35
Vilaça, N., Bertão, A. R., Prasetyanto, E. A., Granja, S., Costa, M. F., Fernandes, R., Figueiredo, F., Fonseca, A. M. C., Cola, L. D., Baltazar, F., et al. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111721 · Cited by 42
Conductive Materials with Elaborate Micro/Nanostructures for Bioelectronics
Guo, J., Wang, Y., Zhang, H., & Zhao, Y. (2022) · Advanced Materials · doi:10.1002/adma.202110024 · Cited by 36
Zheng, D., Zhou, J., Qian, L., Liu, X., Chang, C., Tang, S., Zhang, H., & Zhou, S. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.10.025 · Cited by 37
“Therefore, we exploited the homologous aggregation and immune escape properties of tumor cells to confer the nanoparticles with targeting ability and to enhance their circulation in vivo [32,70].”
MethodBrar, B., Marwaha, S., Poonia, A. K., Koul, B., Kajla, S., & Rajput, V. D. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03404-3 · Cited by 48
Liu, J., Yu, X., Braucht, A., Smith, S., & Wang, C. (2024) · ACS Nano · doi:10.1021/acsnano.3c12281 · Cited by 35
Hei, M., Wang, J., Wang, K., Zhu, W. P., & Ma, P. X. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb02429k · Cited by 36
Optical Nanoparticles for Cardiovascular Imaging
Hu, J., Ortgies, D. H., Rodríguez, E. M., Rivero, F., Aguilar, R., Alfonso, F., Fernández, N., Carreño‐Tarragona, G., Monge, L., Sanz-Rodríguez, F., et al. (2018) · Advanced Optical Materials · doi:10.1002/adom.201800626 · Cited by 36
Zamani, M., Kiyaseh, M., Rostamizadeh, K., Manjili, H. K., Fridoni, M., & Danafar, H. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101283 · Cited by 34
Ji, Z., Arvapalli, D. M., Zhang, W., Yin, Z., & Wei, J. (2020) · Journal of Materials Science · doi:10.1007/s10853-020-04419-7 · Cited by 38
“44:4743–4768 [4] Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y (2014) Engineered nanoparticles for drug delivery in cancer therapy.”
BackgroundKhodashenas, B., Ardjmand, M., Baei, M. S., Rad, A. S., & Akbarzadeh, A. (2020) · Applied Organometallic Chemistry · doi:10.1002/aoc.5609 · Cited by 34
In Situ Formation of Polymeric Nanoassemblies Using an Efficient Reversible Click Reaction
Liu, B., Wu, R., Gong, S., Xiao, H., & Thayumanavan, S. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004017 · Cited by 35
Puig-Rigall, J., Blanco‐Prieto, M. J., Rădulescu, A., Dreiss, C. A., & González‐Gaitano, G. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.08.004 · Cited by 35
Lee, H., Kim, S., Oh, C., Khan, I., Shukla̽, S., Bajpai, V. K., Han, Y., & Huh, Y. S. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111343 · Cited by 35
Zhang, S., Zhu, P., He, J., Dong, S., Li, P.-W., Zhang, C. Y., & Ma, T. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000387 · Cited by 34
Zheng, X., Lei, S., Gao, Z., Dong, X., Xiao, H., Liu, W., Tung, C., Wu, L., Wang, P., & Cong, H. (2023) · Chemical Science · doi:10.1039/d3sc00107e · Cited by 34
Strozyk, M. S., Carregal‐Romero, S., Henriksen‐Lacey, M., Brust, M., & Liz‐Marzán, L. M. (2017) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b05471 · Cited by 37
Ming, H., Li, B., Tian, H., Zhou, L., Jiang, J., Zhang, T., Qiao, L., Wu, P., Nice, E. C., Zhang, W., et al. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100289 · Cited by 33
“Recent studies suggest that engineered nanoparticles can transform the physicochemical properties of traditional drugs with poor solubility while achieving the synergistic effect of combined therapy [30].”
BackgroundRecent advances in targeted drug delivery for the treatment of glioblastoma
Mao, M., Wu, Y., & He, Q. Z. (2024) · Nanoscale · doi:10.1039/d4nr01056f · Cited by 37
Nanthini, K. C., Thangam, R., Karthikeyan, L., Rithisa, B., Rasheed, P. A., Min, S., Kang, H., Kannikaparameswari, N., & Vivek, R. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216043 · Cited by 37
Injectable nanorobots for precision cancer therapy: motion-enhanced drug delivery
Gao, Z., Yang, Z., Xu, W., Luo, M., & Guan, J. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00596e · Cited by 41
Mäsing, F., Mardyukov, A., Doerenkamp, C., Eckert, H., Malkus, U., Nüsse, H., Klingauf, J., & Studer, A. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201505133 · Cited by 33
Paul, M., & Dastidar, P. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201503706 · Cited by 34
Liu, Y., Zhang, X., Luo, L., Li, L., He, Y., An, J., & Gao, D. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00766 · Cited by 33
Abdollahi, Z., Taheri‐Kafrani, A., Bahrani, S. A., & Kajani, A. A. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.04.006 · Cited by 33
Applications of Micro/Nanotechnology in Ultrasound-based Drug Delivery and Therapy for Tumor
Sun, S., Wang, P., Sun, S., & Liang, X. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200212100257 · Cited by 34
A synopsis of modern - day colorectal cancer: Where we stand
Ranasinghe, R., Mathai, M. L., & Zulli, A. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188699 · Cited by 40
Luo, Q., Lin, L., Huang, Q., Duan, Z., Gu, L., Zhang, H., Gu, Z., Gong, Q., & Luo, K. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.02.033 · Cited by 33
New Perspectives for Eye-Sparing Treatment Strategies in Primary Uveal Melanoma
Bilmin, K., Synoradzki, K. J., Czarnecka, A. M., Spalek, M. J., Kujawska, T., Solnik, M., Merks, P., Toro, M. D., Ręjdak, R., & Fiedorowicz, M. (2021) · Cancers · doi:10.3390/cancers14010134 · Cited by 37
“These compounds possess good solubility and could prolong blood circulation and accumulate in tumor lesion sites [97].”
BackgroundZhang, M., Ran, S., Yin, X., Zhang, J., Sun, X. J., Sun, W., & Zhu, Z. (2023) · BMEMat · doi:10.1002/bmm2.12041 · Cited by 34
Sun, J., Xie, W., Zhu, X., Xu, M., & Liu, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00312 · Cited by 33
Intracellular and extracellular enzymatic responsive micelle for intelligent therapy of cancer
Wan, D., Zhu, Q., Zhang, J., Chen, X., Li, F., Liu, Y., & Pan, J. (2022) · Nano Research · doi:10.1007/s12274-022-4967-1 · Cited by 32
Zhang, H., Xue, Q., Zhou, Z., He, N., Li, S., & Zhao, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1176232 · Cited by 33
“Among the many parameters, the size of the NPs played an important role in the EPR effect, with a cut-off size of approximately 400 nm for penetration into the tumour, with particles less than 200 nm in diameter being the most effective (Sun et al., 2014).”
BackgroundNano‐bio‐interface: Unleashing the Potential of Noble Nanometals
Guo, P., Wang, Y., Cui, H., Yao, X., Guan, G., & Han, M. (2024) · Small Science · doi:10.1002/smsc.202300227 · Cited by 33
Nanomaterials for targeted therapy of kidney diseases: Strategies and advances
Wang, Z., & Zhang, C. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101534 · Cited by 49
“Due to their controllable nanostructure, large surface area, diverse surface chemistry, and unique optical and magnetic properties, inorganic nanoparticles have demonstrated immense potential in nanomedicine [96].”
Gou, Y., Zhang, Z., Qi, J., Liang, S., Zhou, Z., Yang, F., & Liang, H. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.09.004 · Cited by 32
Wang, X., Gao, W., Fan, H., Ding, D., Lai, X.-F., Zou, Y., Chen, L., Chen, Z., & Tan, W. (2016) · Nanoscale · doi:10.1039/c6nr00369a · Cited by 32
Adinolfi, B., Pellegrino, M., Giannetti, A. E., Tombelli, S., Trono, C., Sotgiu, G., Varchi, G., Ballestri, M., Posati, T., Carpi, S., et al. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.05.102 · Cited by 32
“…by different approaches: a) incorporation into the NP core, either by cleavable covalent bonds or by hydrophobic interactions (Gao et al., 2006); b) covalently bonded on the surface through a cleavable linker (Sun et al., 2014); c) electrostatically loaded on the external shell (Monasterolo 2012).”
Engineering of nanoparticle size via electrohydrodynamic jetting
Rahmani, S., Ashraf, S., Hartmann, R., Dishman, A. F., Zyuzin, M. V., Yu, C. K. J., Parak, W. J., & Lahann, J. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10010 · Cited by 32
“5,9 To quantify this data and determine the absolute number of internalized fl uorescent nanoparticles per cell, an average integrated For determining the distribution of integrated fl uorescence intensity per nanoparticle, individual nanoparticles were segmented applying the following procedure: (a)…”
Cui, S., Pan, X., Gebru, H., Wang, X., Liu, J., Liu, J., Li, Z., & Guo, K. (2017) · Journal of Materials Chemistry B · doi:10.1039/c6tb02145j · Cited by 36
Hwang, J., Son, J., Seo, Y., Jo, Y., Lee, K., Lee, D., Khan, M. S., Chavan, S. G., Park, C., Sharma, A., et al. (2017) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2017.09.051 · Cited by 32
Nanoparticles for death‑induced gene therapy in cancer (Review)
Roacho-Pérez, J. A., Gallardo‐Blanco, H. L., Sánchez‐Domínguez, M., García‐Casillas, P. E., González, C. C., & Sanchez-Dominguez, C. N. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8091 · Cited by 42
“The nanosystem has the physicochemical properties to interact and cross the epithelium (55-56).”
InfluentialCao‐Luu, N., Pham, Q., Yao, Z.-H., Wang, F., & Chern, C. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.10.091 · Cited by 34
Protein and mRNA Delivery Enabled by Cholesteryl‐Based Biodegradable Lipidoid Nanoparticles
Li, Y., Jarvis, R., Zhu, K., Glass, Z., Ogurlu, R., Gao, P., Li, P., Chen, J., Yu, Y., Yang, Y., et al. (2020) · Angewandte Chemie · doi:10.1002/ange.202004994 · Cited by 34
Lai, X., Geng, X., Tan, L., Hu, J., & Wang, S. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s260069 · Cited by 33
Porozhnyy, M. V., Shkirskaya, S. A., Butylskii, D. Y., Dotsenko, V. V., Safronova, E. Y., Yaroslavtsev, A. B., Deabate, S., Huguet, P., & Nikonenko, V. (2021) · Electrochimica Acta · doi:10.1016/j.electacta.2020.137689 · Cited by 32
Hayat, K., Ali, S., Ullah, S., Fu, Y., & Hussain, M. (2021) · Green Processing and Synthesis · doi:10.1515/gps-2021-0010 · Cited by 36
“The science deals with the production of minute particles having dimension between 1 and 100 nm [14].”
BackgroundCo-Adjuvant Nanoparticles for Radiotherapy Treatments of Oncological Diseases
Crapanzano, R., Secchi, V., & Villa, I. (2021) · Applied Sciences · doi:10.3390/app11157073 · Cited by 37
“Moreover, the engineering of the NPs surfaces by targeting ligands enables the specificity of their diagnostic and therapeutic activity towards the malignancy and illness sites in the patients’ body and the release of the antitumoral drugs in a stable and controlled manner [51,52].”
BackgroundBraga, C. B., Pilli, R. A., Ornelas, C., & Weck, M. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c01196 · Cited by 34
Bhangu, S. K., Fernandes, S., Beretta, G. L., Tinelli, S., Cassani, M., Radziwon, A., Wojnilowicz, M., Sarpaki, S., Pilatis, I., Zaffaroni, N., et al. (2022) · Advanced Materials · doi:10.1002/adma.202107964 · Cited by 33
Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy
Tu, Y., Zhang, W., Fan, G., Zou, C., Zhang, J., Wu, N., Ding, J., Zou, W., Xiao, H., & Tan, S. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2189106 · Cited by 33
“However, the insufficient release of nanomedicines in cells limits their clinical application (Fang et al., 2011; Sun et al., 2014).”
Background
Metadata
- Authors
- Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y.
- Affiliations
- Georgia Institute of Technology (US)
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2014-10-07
- Volume
- 53
- Issue
- 46
- Pages
- 12320-12364
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2134726513
- Cited by
- 2,164
- References
- 578
- Citations by year
- 2026: 57 · 2025: 146 · 2024: 163 · 2023: 153 · 2022: 209 · 2021: 200 · 2020: 221 · 2019: 237 · 2018: 257 · 2017: 230 · 2016: 180 · 2015: 109 · 2014: 2
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- engineered nanoparticles, drug delivery, cancer therapy, targeted drug delivery, enhanced permeability and retention effect, pH-responsive delivery, tumor-targeting ligands, tissue distribution, circulation half-life, immunogenicity, combination therapy, multidrug resistance, contrast media, theranostics, nanoparticle surface modification
- MeSH terms
- Animals, Antineoplastic Agents, Delayed-Action Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanotechnology, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.